Curious about today's AI digest?ai-tldr.dev

Daily Digest

Pomegra Startups

Startup News

Funding rounds, valuations, acquisitions, and IPOs - daily coverage of the companies shaping the private markets

Isomorphic Labs raises $5B Series C in 2026
FundingBiotech
MAJOR
4 min read

Isomorphic Labs raises $5B Series C in 2026

Isomorphic Labs, the AI drug-discovery company, raised a $5B Series C to push its drug candidates toward clinical trials.

Orakl Oncology Raises $34M Series A in 2026 Round
FundingBiotech
NOTABLE
4 min read

Orakl Oncology Raises $34M Series A in 2026 Round

French biotech Orakl Oncology raised a $34M Series A for AI-driven predictive oncology using patient-derived tumor models.

Switchpoint Bio's $5.3M Pre-Seed Targets Drug Response
FundingBiotech
NOTABLE
4 min read

Switchpoint Bio's $5.3M Pre-Seed Targets Drug Response

Switchpoint Bio (Finland/UK) emerged from stealth with a $5.3M pre-seed to study why patients respond differently to drugs.

Biomatter raises $18M Series A for Vilnius enzyme lab
FundingBiotech
NOTABLE
5 min read

Biomatter raises $18M Series A for Vilnius enzyme lab

Biomatter (Lithuania) raised $18M from Astanor and UVC Partners to build an enzyme lab in Vilnius.

Neurosterix Raises $105M Series B for Schizophrenia Drug
FundingBiotech
NOTABLE
4 min read

Neurosterix Raises $105M Series B for Schizophrenia Drug

Neurosterix (Switzerland/US) raised $105M to advance experimental treatments for schizophrenia and other neurological conditions.

Neobe raises €6.1M seed for tumour-busting bacteria
FundingBiotech
NOTABLE
4 min read

Neobe raises €6.1M seed for tumour-busting bacteria

Neobe (UK) raised €6.1M to engineer bacteria that break down the barriers protecting tumours.

Anaheim Bio raises €40M Series A for CPPD drug in 2026
FundingBiotech
NOTABLE
4 min read

Anaheim Bio raises €40M Series A for CPPD drug in 2026

Anaheim Bio (Netherlands) raised €40M to develop a treatment for calcium pyrophosphate deposition disease.

bit.bio Series D 2026: $25M for lab-grown human cells
FundingBiotech
NOTABLE
4 min read

bit.bio Series D 2026: $25M for lab-grown human cells

bit.bio (Cambridge, UK), a human cell programming company, closed a $25M Series D for lab-grown human cell models.

Transpharmation Buys OrganoTherapeutics: 2026 CRO Deal
AcquisitionsBiotech
NOTABLE
4 min read

Transpharmation Buys OrganoTherapeutics: 2026 CRO Deal

Transpharmation (UK) acquired OrganoTherapeutics, a Luxembourg startup building patient-derived brain organoid models.

Samplix €25M First Close Led by WLan: 2026 Funding Explained
FundingBiotech
NOTABLE
4 min read

Samplix €25M First Close Led by WLan: 2026 Funding Explained

Samplix, a Danish biotech, secured €25M in the first close of a financing round.

Warhound Raises $200M Seed to Clone Military Dogs in 2026
FundingBiotech
MAJOR
4 min read

Warhound Raises $200M Seed to Clone Military Dogs in 2026

Warhound, a US startup using genetics and cloning to breed military working dogs, raised a $200M seed round.

Nouscom €120M Series D: Lynch Syndrome Vaccine in 2026
FundingBiotech
NOTABLE
4 min read

Nouscom €120M Series D: Lynch Syndrome Vaccine in 2026

Swiss biotech Nouscom raised a €120M Series D for its cancer-prevention immunotherapy for Lynch syndrome.

Page 1 of 4 · 40 stories